---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-24-007371"
form_type: "8-K"
ticker: "CNSP"
cik: "0001729427"
company_name: "CNS Pharmaceuticals, Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:34:21.108481+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# CNS Pharmaceuticals prices $3M registered direct offering of common stock and pre-funded warrants at $0.17/share

## Summary
- Gross proceeds ~$3M from sale of 3.7M common shares and pre-funded warrants for 13.9M shares at $0.17/share.
- A.G.P./Alliance Global Partners acting as sole placement agent; receives 6.5% fee plus up to $90k expenses.
- Closing expected Oct 24, 2024; proceeds for working capital and general corporate purposes.
- After partial exercise of pre-funded warrants, company now has 49,574,933 shares outstanding.

## SEC filing metadata
- accession: 0001683168-24-007371
- form_type: 8-K
- ticker: CNSP
- cik: 0001729427
- company_name: CNS Pharmaceuticals, Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1729427/000168316824007371/0001683168-24-007371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1729427/000168316824007371/cns_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-24-007371
- JSON: https://secwatch.observer/filing/0001683168-24-007371.json
- Plain text: https://secwatch.observer/filing/0001683168-24-007371.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.